Gout is one of the most common metabolic disorders in human caused by inflammatory responses to the deposition of monosodium urate (MSU) crystals , which form in the presence of increased urate concentrations. The pathogenesis of gout is that MSU crystal triggers strong inflammatory response by activating macrophages in tissues and promoting the collection of neutrophils to tissues or organs [1]. It has been reported that many soluble mediators are implicated in the initiation and amplification of the gout flare, including pro-inflammatory cytokines, lipid mediators and complement [2]. However, activation of the NOD-, LRR-and pyrin domain-containing protein 3 (NLRP3) inflammasome by monosodium urate crystals with release of IL-1β plays a major role in the initiation of the gout flare [3]. Interestingly, the gout flare is a self-limiting inflammation, and several mechanisms of resolution have been proposed, such as neutrophil extracellular traps [4], negative regulators of inflammasome and TLR signaling, and anti-inflammatory cytokines [5].It is noteworthy that gout is closely related to many comorbidities [6], especially cardiovascular diseases. To further our understanding of inflammatory regulation in the molecular pathophysiology of gout and to explore potential therapeutic approaches , this special issue exhibits a number of original research articles and review papers on the topic of advances in pathogenesis and therapies of gout. Galectin-9 (Gal-9) is a modulator of innate and adaptive immunity with both proand anti-inflammatory functions, dependent upon its expression and cellular location [11]. Using mouse models of gout, Mansour et al investigated the action of exogenous Gal-9 in MSU-gouty inflammation, which provide a new therapeutic strategy for preventing tissue damage in gouty arthritic inflammation. Elsaid et al examined the anti-inflammatory mechanism of proteoglycan 4(rhPRG4) in MSU stimulated monocytes by animal model, Their work indicates that rhPRG4 exerts an anti-inflammatory activity in gout PBMCs, mediated by its ability to reduce urate crystal phagocytosis. Si-Miao-San (SMS)is a traditional Chinese medicine that has been reported to relieve the symptoms of gouty arthritis [12]. A research by Cao et al explored the anti-inflammatory mechanism of SMS on gout through animal and cellular experiments.Uric acid is excreted mainly through the kidneys and intestines.A mini review by Yin et al summarized the effects of intestinal uric acid transporters and intestinal flora on uric acid excretion.Collectively, the original research and review articles in this special issue cover a series of important aspects in the field of inflammatory regulation and clinical management in gout which may provide new insights into the diagnosis and treatment of gout and hyperuricemia.
14 Authors
- MZ
Mei Zhang
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, China
- XZ
Xiaoxia Zhu
Division of Rheumatology, Huashan Hospital, Fudan University, China
- JW
Jing Wu
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, China
- ZH
Zhengjing Huang
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, China
- ZZ
Zhenping Zhao
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, China
- XZ
Xiao Zhang
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, China
- YX
Yu Xue
Division of Rheumatology, Huashan Hospital, Fudan University, China
- WW
Weiguo Wan
Division of Rheumatology, Huashan Hospital, Fudan University, China
- CL
Chun Li
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, China
- WZ
Wenrong Zhang
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, China
- LW
Linhong Wang
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, China
- MZ
Maigeng Zhou
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, China
- HZ
Hejian Zou
Division of Rheumatology, Huashan Hospital, Fudan University, China
- LW
Limin Wang
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, China
6 Authors
- SL
Shuangshuang Li
Department of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, China
- GX
Guanhua Xu
Department of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, China
- JL
Junyu Liang
Department of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, China
- LW
Liyan Wan
Department of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, China
- HC
Heng Cao
Department of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, China
- JL
Jin Lin
Department of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, China
12,997 views
34 citations
8 Authors
- KQ
Kangli Qiu
Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
- TZ
Tianshu Zeng
Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
- YL
Yunfei Liao
Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
- JM
Jie Min
Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
- NZ
Nan Zhang
Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
- MP
Miaomiao Peng
Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
- WK
Wen Kong
Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
- LC
Lu-lu Chen
Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
7,478 views
24 citations
3 Authors
- XL
Xiaoling Li
Department of Rheumatology and Immunology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, China
- JG
Jie Gao
Department of Rheumatology and Immunology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, China
- JT
Jinhui Tao
Department of Rheumatology and Immunology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, China
7,245 views
19 citations
6 Authors
- SE
Sandy ElSayed
Department of Biomedical and Pharmaceutical Sciences, Chapman University, United States
- GD
Gregory D. Jay
Department of Emergency Medicine, Rhode Island Hospital, United States
- RC
Ralph Cabezas
Department of Emergency Medicine, Rhode Island Hospital, United States
- MQ
Marwa Qadri
Department of Pharmacology, School of Pharmacy, Jazan University, Saudi Arabia
- TA
Tannin A. Schmidt
Biomedical Engineering Department, University of Connecticut Health Center, United States
- KA
Khaled A. Elsaid
Department of Biomedical and Pharmaceutical Sciences, Chapman University, United States
5,022 views
19 citations
